ClinicalTrials.gov
ClinicalTrials.gov Menu

Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01827163
Recruitment Status : Active, not recruiting
First Posted : April 9, 2013
Last Update Posted : April 18, 2018
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center